Thank you, and I should have used the term BIS device in some of my posts above.
Question.... assuming hospitals don't care about patient outcomes (let's assume that just the doctors do) the implementation of a BIS device has to be financially beneficial in at least two categories. 1) They can make money from testing using a BIS device and 2) They won't get sued if they don't have a BIS device. Again my understanding is that if other hospitals in the area/state have a BIS device which could have been used to prevent their lymphoedema then the patient can sue the hospital because the device is included in the NCCN guidelines.
Show me the money.... if it's just about the money then is that the equation that everyone else sees?
Thank you, and I should have used the term BIS device in some of...
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.9¢ |
Change
0.003(3.49%) |
Mkt cap ! $180.0M | |||
| Open | High | Low | Value | Volume |
| 8.6¢ | 8.9¢ | 8.3¢ | $123.6K | 1.451M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 480587 | 8.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.9¢ | 14999 | 1 |
View Market Depth
| Last trade - 16.10pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
8.5¢ |
Change
0.003 ( 2.07 %) |
||||
| Open | High | Low | Volume | ||
| 8.6¢ | 8.8¢ | 8.3¢ | 703656 | ||
| Last updated 15.59pm 29/04/2024 ? | |||||
| IPD (ASX) Chart |